1–2 of 2 results for Szilárd Kiss
Interim Results and Key Learnings from an Ongoing Phase 2 Study of Encapsulated Cell Therapy Compared to Aflibercept in Patients With Wet AMD
Szilárd Kiss, MD
Annual Meeting Talks
2016
Subretinal Gene Therapy Delivery
Updates from the Field
2018